Hanna-Riikka Teppo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Transcription Factor

Bioinformatics Analysis

Basal Cell Carcinoma

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Marjaana J Häyrinen, Jenni Kiiskilä, Annamari Ranki, Liisa Väkevä, Henry J Barton, Milla E L Kuusisto, Katja Porvari, Hanne Kuitunen, Kirsi-Maria Haapasaari, Hanna-Riikka Teppo, Outi Kuittinen
The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases. Cancers 15 (5) (2023)
Marjaana J Häyrinen, Jenni Kiiskilä, Annamari Ranki, Liisa Väkevä, Henry J Barton, Milla E L Kuusisto, Katja Porvari, Hanne Kuitunen, Kirsi-Maria Haapasaari, Hanna-Riikka Teppo, Outi Kuittinen
The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases. Cancers 15 (5) (2023)
Anni Immonen, Kirsi-Maria Haapasaari, Sini Skarp, Peeter Karihtala, Hanna-Riikka Teppo
NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma. Oxidative medicine and cellular longevity 2022 (2022)
Bijay Ratna Shakya, Hanna-Riikka Teppo, Lassi Rieppo
Optimization of measurement mode and sample processing for FTIR microspectroscopy in skin cancer research. The Analyst 147 (5) (2022)
Mikko C Chan, Janette Savela, Riina K Ollikainen, Hanna-Riikka Teppo, Ilkka Miinalainen, Risto Pirinen, Esa J M Kari, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Milla E L Kuusisto
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation. Oxidative medicine and cellular longevity 2021 (2021)